Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Centene Corp Q1 Net Income Slips; Revises FY 2012 Guidance - Quick Facts

RELATED NEWS
Trade CNC now with 

Centene Corp. (CNC: Quote) Tuesday reported net ear nings of $23.97 million for the first quarter of fiscal 2012, flat with net earnings of $23.74 million reported for the coerresponding first quarter of last year.

Earnings per diluted share for the first quarter of 2012 declined to $0.45 from $0.46 per diluted share reported for the year-ago quarter.

Commenting on the results, Michael F. Neidorff, Chairman and Chief Executive Officer, stated, "While underlying trend remains predictable, results were mixed due to seasonality of medical costs particularly in March, continued high medical costs in Kentucky, and general and administrative costs at higher levels associated with an additional 370,000 members in Texas…"

Seventeen analysts polled by Thomson Reuters estimated earnings of $0.49 per share for the first quarter. Analysts' estimates usually exclude special items.

Total Revenue for the first quarter increased to $1.71 billion from $1.22 billion reported for the year-ago quarter. Of the total revenues, , premium revenues were $1.64 billion in this quarter compared with $1.15 billion in the corresponding quarter last year.

Nine analysts polled by Thomson Reuters estimated revenues of $1.64 billion for the first quarter.

Looking ahead for full year 2012, the company has revised its Earnings outlook and now expects EPS in the range between $2.64 to $2.84 from its earlier guidance range between $2.60 to $2.80 per share.

The company has also revised its Revenue guidance for 2012 upwards and now expects Revenue to range between $7.70 billion and $8.10 billion from its earlkier guidance range between $7.20 billion to - $7.60 billion.

Register
To receive FREE breaking news email alerts for Centene Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.